跳转至内容
Merck
CN
  • Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions.

Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions.

Autophagy (2014-12-04)
Shane Deegan, Svetlana Saveljeva, Susan E Logue, Karolina Pakos-Zebrucka, Sanjeev Gupta, Peter Vandenabeele, Mathieu J M Bertrand, Afshin Samali
摘要

Endoplasmic reticulum (ER) stress-induced cell death is normally associated with activation of the mitochondrial apoptotic pathway, which is characterized by CYCS (cytochrome c, somatic) release, apoptosome formation, and caspase activation, resulting in cell death. In this study, we demonstrate that under conditions of ER stress cells devoid of CASP9/caspase-9 or BAX and BAK1, and therefore defective in the mitochondrial apoptotic pathway, still undergo a delayed form of cell death associated with the activation of caspases, therefore revealing the existence of an alternative stress-induced caspase activation pathway. We identified CASP8/caspase-8 as the apical protease in this caspase cascade, and found that knockdown of either of the key autophagic genes, ATG5 or ATG7, impacted on CASP8 activation and cell death induction, highlighting the crucial role of autophagy in the activation of this novel ER stress-induced death pathway. In line with this, we identified a protein complex composed of ATG5, FADD, and pro-CASP8 whose assembly coincides with caspase activation and cell death induction. Together, our results reveal the toxic potential of autophagy in cells undergoing ER stress that are defective in the mitochondrial apoptotic pathway, and suggest a model in which the autophagosome functions as a platform facilitating pro-CASP8 activation. Chemoresistance, a common problem in the treatment of cancer, is frequently caused by the downregulation of key mitochondrial death effector proteins. Alternate stress-induced apoptotic pathways, such as the one described here, may become of particular relevance for tackling the problem of chemoresistance in cancer cells.

材料
产品编号
品牌
产品描述

Roche
不含EDTA的cOmplete Mini蛋白酶抑制剂混合物, Protease Inhibitor Cocktail Tablets provided in a glass vial, Tablets provided in a glass vial
Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
嘌呤霉素 二盐酸盐 来源于白色链球菌, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
IGEPAL® CA-630, Molecular Biology
Sigma-Aldrich
氯喹 二磷酸盐, powder or crystals, 98.5-101.0% (EP)
Sigma-Aldrich
毒胡萝卜素, ≥98% (HPLC), solid film
Sigma-Aldrich
皂素, Molecular Biology, used as non-ionic surfactant
Sigma-Aldrich
乙二胺四乙酸, BioUltra, anhydrous, ≥99% (titration)
Sigma-Aldrich
抗-LC3B 兔抗, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗小鼠IgG(全分子)–FITC 山羊抗, affinity isolated antibody, buffered aqueous solution